Literature DB >> 35325321

Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets.

Long-Xia Li1, Fang-Fang Guo2, Hong Liu1, Tao Zeng3.   

Abstract

Alcoholic liver disease (ALD) is a global public health challenge due to the high incidence and lack of effective therapeutics. Evidence from animal studies and ALD patients has demonstrated that iron overload is a hallmark of ALD. Ethanol exposure can promote iron absorption by downregulating the hepcidin expression, which is probably mediated by inducing oxidative stress and promoting erythropoietin (EPO) production. In addition, ethanol may enhance iron uptake in hepatocytes by upregulating the expression of transferrin receptor (TfR). Iron overload in the liver can aggravate ethanol-elicited liver damage by potentiating oxidative stress via Fenton reaction, promoting activation of Kupffer cells (KCs) and hepatic stellate cells (HSCs), and inducing a recently discovered programmed iron-dependent cell death, ferroptosis. This article reviews the current knowledge of iron metabolism, regulators of iron homeostasis, the mechanism of ethanol-induced iron overload, detrimental effects of iron overload in the liver, and potential therapeutic targets.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Alcoholic liver disease; Ferroptosis; Hepcidin; Iron overload

Mesh:

Substances:

Year:  2022        PMID: 35325321     DOI: 10.1007/s00018-022-04239-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  140 in total

1.  Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study.

Authors:  Jakob Manthey; Kevin D Shield; Margaret Rylett; Omer S M Hasan; Charlotte Probst; Jürgen Rehm
Journal:  Lancet       Date:  2019-05-07       Impact factor: 79.321

2.  Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases.

Authors:  Katherine Dang; Grishma Hirode; Ashwani K Singal; Vinay Sundaram; Robert J Wong
Journal:  Am J Gastroenterol       Date:  2020-01       Impact factor: 10.864

Review 3.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

4.  Kupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosis.

Authors:  P Stål; U Broomé; A Scheynius; R Befrits; R Hultcrantz
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

5.  ACG Clinical Guideline: Alcoholic Liver Disease.

Authors:  Ashwani K Singal; Ramon Bataller; Joseph Ahn; Patrick S Kamath; Vijay H Shah
Journal:  Am J Gastroenterol       Date:  2018-01-16       Impact factor: 10.864

Review 6.  Systemic iron homeostasis.

Authors:  Tomas Ganz
Journal:  Physiol Rev       Date:  2013-10       Impact factor: 37.312

Review 7.  Iron, meat and health.

Authors:  Catherine Geissler; Mamta Singh
Journal:  Nutrients       Date:  2011-02-28       Impact factor: 5.717

Review 8.  Epidemiology of alcoholic liver disease in Korea.

Authors:  Jae Young Jang; Dong Joon Kim
Journal:  Clin Mol Hepatol       Date:  2018-03-16

9.  Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.

Authors:  Zhenqiu Liu; Xianhua Mao; Yanfeng Jiang; Ning Cai; Li Jin; Tiejun Zhang; Xingdong Chen
Journal:  Cancer Med       Date:  2019-08-06       Impact factor: 4.452

View more
  5 in total

Review 1.  Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.

Authors:  Kevin Ferrao; Najma Ali; Kosha J Mehta
Journal:  J Mol Med (Berl)       Date:  2022-10-10       Impact factor: 5.606

2.  Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization.

Authors:  Bin Huang; Wenjie Wen; Shandong Ye
Journal:  Oxid Med Cell Longev       Date:  2022-08-10       Impact factor: 7.310

Review 3.  Advancements in the Alcohol-Associated Liver Disease Model.

Authors:  Lin Zhu; Hai-Di Li; Jie-Jie Xu; Juan-Juan Li; Miao Cheng; Xiao-Ming Meng; Cheng Huang; Jun Li
Journal:  Biomolecules       Date:  2022-07-27

Review 4.  Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target.

Authors:  Yunqing Chen; Yan Xu; Kan Zhang; Liang Shen; Min Deng
Journal:  Front Cell Infect Microbiol       Date:  2022-07-27       Impact factor: 6.073

Review 5.  Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders.

Authors:  Li Lu; Yuan Xiong; Ze Lin; Xiangyu Chu; Adriana C Panayi; Yiqiang Hu; Juan Zhou; Bobin Mi; Guohui Liu
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.